Coal India Limited Mukesh Choudhary Appointed Additional Director (Human Resource)
Coal India Limited (CIL) announced the appointment of Shri Mukesh Choudhary as the Additional Director (Human Resource), entrusting him with…
Infosys Powers NTN Corporation’s Digital Growth with SAP Commerce Cloud Adoption
Infosys has successfully migrated NTN Corporation’s on-premise SAP Commerce-based e-commerce platform, e-WINGS, to SAP Commerce Cloud…
Larsen & Toubro Secures Ultra-Mega Framework Agreement with TenneT for 2 GW Offshore Wind Programme
Larsen & Toubro (L&T) has announced the conclusion of a Framework Cooperation Agreement (FCA) with TenneT for a 2 GW offshore wind…
Shyam Metalics and Energy Limited Shyam Sel and Power Commissions 8.90 MWp Solar Project
Shyam Sel and Power Limited, a subsidiary of Shyam Metalics and Energy Limited, has successfully commissioned an 8.90 MWp solar power project…
Coforge Board Approves Unaudited Financial Results and Declares Interim Dividend
Coforge Limited announced its un-audited standalone and consolidated financial results for the quarter ended June 30, 2026. The Board of…
Coforge Limited Board Approves Unaudited Financial Results and Interim Dividend for Q1 FY27
Coforge Limited announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The Board of…
Coforge Limited Announces Interim Dividend and Record Date for FY 2026-27
Coforge Limited’s Board of Directors has declared an interim dividend of Rs. 4/- per Equity Share for the Financial Year 2026-27. The…
Coforge Announces Q1 FY27 Unaudited Financial Results and Interim Dividend
Coforge Limited has announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The company…
Coforge Announces Strong Q1 FY27 Financial Results with 49% YoY Revenue Growth
Coforge Limited reported robust financial results for the first quarter of Fiscal Year 2027 (Q1 FY27), ending June 30, 2026. The company…
Cipla Receives U.S. FDA Approval for Generic Advair Diskus
Cipla Limited announced on July 27, 2026, that it has received U.S. FDA approval for its Generic Advair Diskus®, a combination therapy for…